Oxygen Effect and Radiosensitizers — MCQs
Which of the following statements about thyroid eye disease is false?
Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
Which compound is not considered as a radiosensitizer?
A patient with cancer received an extreme degree of radiation toxicity. Further history revealed that the dose adjustment of a particular drug was missed during the course of radiotherapy. Which of the following drugs required a dose adjustment in that patient during radiotherapy to prevent radiation toxicity?
Most radiosensitive tumor among the following is
When is oxygen effective during radiotherapy?
Which of the following is/are most radioresistant?
At the end of anaesthesia after discontinuation of nitrous oxide and removal of endotracheal tube, 100% oxygen is administered to the patient to prevent:
Which factor has the most significant influence on the oxygen dissociation curve?
Which factor predominantly influences the rightward shift of the oxygen dissociation curve?
Oxygen Effect and Radiosensitizers Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following statements about thyroid eye disease is false?
- A. NOSPECS score is used to classify thyroid eye disease
- B. The management corresponds to improvement in thyrotoxic state (Correct Answer)
- C. Can lead to visual loss
- D. Seen in more than 10% of patients with hyperthyroidism
Explanation: ***The management corresponds to improvement in thyrotoxic state*** - Thyroid eye disease (TED) is an **autoimmune condition** that runs independently of the thyroid's hormonal status [1]. While hyperthyroidism can trigger or worsen TED, treating the hyperthyroidism does not necessarily resolve or improve the eye symptoms [2]. - The disease course of TED is often **biphasic**, with an active inflammatory phase followed by a quiescent phase. Treatment decisions for TED are based on the severity and activity of the eye disease itself, not solely on the thyroid hormone levels. *NOSPECS score is used to classify thyroid eye disease* - The **NOSPECS classification system** is a well-established method for grading the severity of thyroid eye disease. - This acronym stands for **N**o signs or symptoms, **O**nly signs (e.g., lid retraction) no symptoms, **S**oft tissue involvement, **P**roptosis, **E**xtraocular muscle involvement, **C**orneal involvement, and **S**ight loss (optic neuropathy). *Can lead to visual loss* - Thyroid eye disease can cause **optic nerve compression** due to enlarged extraocular muscles or increased orbital fat, leading to **compressive optic neuropathy** and potentially irreversible visual loss. - Severe **corneal exposure** from proptosis and lid retraction can also lead to corneal ulceration, infection, and scaring, affecting vision. *Seen in more than 10% of patients with hyperthyroidism* - Thyroid eye disease is the **most common extrathyroidal manifestation** of Graves' disease, occurring in approximately 25-50% of patients with Graves' hyperthyroidism [1]. - While it is less common in other forms of hyperthyroidism or euthyroid individuals, the prevalence in Graves' disease alone is significantly higher than 10%.
Question 2: Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
- A. Cyclophosphamide
- B. Methotrexate
- C. Cisplatin (Correct Answer)
- D. Dacarbazine
Explanation: ***Cisplatin*** - **Cisplatin** is a platinum-based chemotherapy drug that forms **DNA cross-links**, inhibiting DNA synthesis and leading to the death of rapidly dividing cells, making it highly effective against **ovarian carcinoma**. - It is a cornerstone of chemotherapy regimens for ovarian cancer, often used in combination with other agents such as paclitaxel. *Methotrexate* - **Methotrexate** is an **antimetabolite** that inhibits dihydrofolate reductase, thereby interfering with DNA synthesis. - While it is used in various cancers like leukemia, lymphoma, and some solid tumors (e.g., breast cancer, gestational trophoblastic disease), it is **not a primary recommended drug for ovarian carcinoma**. *Cyclophosphamide* - **Cyclophosphamide** is an **alkylating agent** that causes DNA damage, leading to cell death. - It is used in many cancers, including lymphoma, breast cancer, and some leukemias, but it is **not a first-line or primary agent for ovarian carcinoma** in contemporary treatment guidelines. *Dacarbazine* - **Dacarbazine** is an **alkylating agent** primarily used in the treatment of **malignant melanoma** and Hodgkin lymphoma. - It is **not indicated for the treatment of ovarian carcinoma**.
Question 3: Which compound is not considered as a radiosensitizer?
- A. Hyperbaric oxygen
- B. Misonidazole
- C. Amifostine (Correct Answer)
- D. Idoxuridine
Explanation: ***Amifostine*** - **Amifostine** is a **radioprotector**, meaning it selectively protects healthy cells from the damaging effects of radiation, rather than enhancing radiation's effect on tumor cells. - It works by being dephosphorylated by alkaline phosphatase in normal tissues to an active thiol metabolite that scavenges **free radicals** generated by radiation. *Hyperbaric oxygen* - **Hyperbaric oxygen** increases the amount of dissolved oxygen in tissues, which is a potent **radiosensitizer**. - **Oxygen** enhances the formation of **free radicals** and fixes radiation-induced DNA damage, making tumor cells more susceptible to radiation. *Misonidazole* - **Misonidazole** is a **hypoxic radiosensitizer** that mimics oxygen, becoming relatively toxic under hypoxic conditions (common in tumors). - It forms **free radicals** and binds to cellular macromolecules when reduced by nitroreductases in hypoxic cells, thereby enhancing the effects of radiation. *Idoxuridine* - **Idoxuridine** is a **halogenated pyrimidine** that acts as a radiosensitizer by being incorporated into DNA in place of thymidine. - This incorporation sensitizes the DNA to radiation by making it more susceptible to **strand breaks** and other damage.
Question 4: A patient with cancer received an extreme degree of radiation toxicity. Further history revealed that the dose adjustment of a particular drug was missed during the course of radiotherapy. Which of the following drugs required a dose adjustment in that patient during radiotherapy to prevent radiation toxicity?
- A. Dactinomycin (Correct Answer)
- B. Vincristine
- C. Cyclophosphamide
- D. 6-Mercaptopurine
Explanation: ***Dactinomycin*** - **Dactinomycin (Actinomycin D)** is known to potentiate radiation effects, meaning it can significantly increase the tissue damage from radiation. - When given concurrently with radiation or prior to radiation, its dose must be carefully adjusted or avoided to prevent severe radiation toxicity, including **radiation recall** phenomena. *Vincristine* - **Vincristine** is a vinca alkaloid primarily used for its antimitotic activity, interfering with microtubule formation. - While it has its own significant toxicities (e.g., neurotoxicity), it is not typically associated with directly potentiating radiation toxicity to the same extent as dactinomycin, nor does it commonly require dose adjustment due to radiation interaction to prevent severe toxicity of this nature. *Cyclophosphamide* - **Cyclophosphamide** is an alkylating agent often used in chemotherapy and immunosuppression. - Although it has various toxicities (e.g., hemorrhagic cystitis, myelosuppression), it is not specifically known for significantly enhancing radiation toxicity in a manner that necessitates routine dose adjustment during concurrent radiotherapy to prevent extreme local radiation effects. *6-Mercaptopurine* - **6-Mercaptopurine** is an antimetabolite primarily used in acute lymphoblastic leukemia. - It interferes with nucleic acid synthesis but is not typically highlighted as a drug that critically requires dose adjustment during radiotherapy to avoid extreme radiation potentiation or recall reactions.
Question 5: Most radiosensitive tumor among the following is
- A. Dysgerminoma (Correct Answer)
- B. Osteogenic sarcoma
- C. Parotid carcinoma
- D. Bronchogenic carcinoma
Explanation: ***Dysgerminoma*** - **Dysgerminomas** are highly **radiosensitive** tumors, meaning they respond very well to radiation therapy. - This characteristic is often exploited in their treatment, especially for widespread disease or as adjuvant therapy. *Osteogenic sarcoma* - **Osteogenic sarcomas** (osteosarcomas) are generally **radioresistant**, requiring high doses of radiation for local control, often with limited success. - Treatment primarily relies on **surgery** and **chemotherapy**. *Parotid carcinoma* - **Parotid carcinomas** exhibit variable radiosensitivity depending on their histology, but generally are not considered among the most radiosensitive tumors. - Postoperative **radiotherapy** is often used for high-risk features rather than as primary monotherapy. *Bronchogenic carcinoma* - **Bronchogenic carcinomas** (lung cancers) show variable radiosensitivity. **Small cell lung carcinoma** is more radiosensitive than **non-small cell lung carcinoma**, but neither is considered as radiosensitive as dysgerminoma. - Treatment often involves **multimodality therapy** including chemotherapy, surgery, and radiation, with radiation efficacy depending on tumor type and stage.
Question 6: When is oxygen effective during radiotherapy?
- A. During and within microseconds of starting (Correct Answer)
- B. Just before starting the therapy
- C. After 5 minutes
- D. After 10 minutes
Explanation: ***During and within microseconds of starting*** - Oxygen is effective during radiotherapy primarily due to the **oxygen enhancement ratio (OER)**, which describes the increased radiosensitivity of cells in the presence of oxygen. - This effect is almost instantaneous, as oxygen acts as a **radical sensitizer** by stabilizing DNA damage caused by radiation, making it irreparable by cellular repair mechanisms. *Just before starting the therapy* - While having oxygen present just before therapy is important, the actual sensitization effect requires oxygen to be present **during** the radiation exposure itself. - Simply having oxygen before without its presence during treatment will not maximize the therapeutic benefit. *After 5 minutes* - The critical period for oxygen's radiosensitizing effect is during and immediately after the ionization events caused by radiation, which occur over **microseconds**. - Oxygen administered 5 minutes after radiation exposure would be too late to impact the initial damage fixation process. *After 10 minutes* - Similar to the 5-minute mark, oxygen delivered 10 minutes after radiation would have **no significant impact** on the immediate radiation-induced cellular damage. - The window of opportunity for oxygen to enhance radiosensitivity is extremely short, occurring at the moment of radiation interaction with biological molecules.
Question 7: Which of the following is/are most radioresistant?
- A. Neurons
- B. Muscle cells
- C. Erythrocytes (Correct Answer)
- D. All of the options
Explanation: ***Erythrocytes*** - Erythrocytes are **anucleated** and terminally differentiated cells, meaning they do not divide. Cells that do not divide are generally **radioresistant**. - Their primary function is oxygen transport, and they have a limited metabolic capacity, making them less susceptible to the genetic damage that typically leads to radiation-induced cell death. *Neurons* - While neurons are **post-mitotic** and generally radioresistant compared to rapidly dividing cells, they are still more susceptible than mature erythrocytes. - High doses of radiation can lead to neuronal damage and death through mechanisms like **apoptosis** and indirect effects from damage to surrounding glial cells and vasculature. *Muscle cells* - Muscle cells (myocytes) are **terminally differentiated** and have a low mitotic rate, making them relatively radioresistant. - However, they are still more sensitive to radiation than erythrocytes, and high doses can cause muscle degeneration and fibrosis. *All of the options* - This option is incorrect because while neurons and muscle cells are relatively radioresistant, **erythrocytes are demonstrably the most radioresistant** among the choices due to their complete lack of a nucleus and inability to divide.
Question 8: At the end of anaesthesia after discontinuation of nitrous oxide and removal of endotracheal tube, 100% oxygen is administered to the patient to prevent:
- A. Second gas effect
- B. Bronchospasm
- C. Hyperoxia
- D. Diffusion Hypoxia (Correct Answer)
Explanation: ***Diffusion Hypoxia*** - Post-anaesthesia administration of 100% oxygen prevents **diffusion hypoxia**, a phenomenon where **nitrous oxide** rapidly diffuses out of the blood into the alveoli, diluting alveolar oxygen and carbon dioxide. - This rapid outflow of nitrous oxide can lead to a significant drop in **partial pressure of oxygen** in the alveoli, causing hypoxemia if not counteracted with high inspired oxygen. *Second gas effect* - The **second gas effect** refers to the phenomenon where the rapid uptake of a highly soluble anesthetic (like nitrous oxide) accelerates the uptake of a co-administered less soluble anesthetic. - This is an effect related to the **induction phase** of anesthesia, not emergence, and is distinct from the issues arising from nitrous oxide washout. *Bronchospasm* - **Bronchospasm** is an acute constriction of the bronchioles, often triggered by irritants, allergens, or certain medications. - While it can occur during emergence from anesthesia, it is not directly prevented by administering 100% oxygen and is typically managed with bronchodilators. *Hyperoxia* - **Hyperoxia** is a condition of excess oxygen in the body, which can be detrimental, but it is not the primary concern immediately following the discontinuation of nitrous oxide. - Administering 100% oxygen in this context is a **controlled, short-term measure** to prevent a more immediate and severe issue (hypoxia) rather than causing chronic hyperoxia.
Question 9: Which factor has the most significant influence on the oxygen dissociation curve?
- A. 2,3-BPG (Correct Answer)
- B. pH
- C. Temperature
- D. All of these
Explanation: ***2,3-BPG*** - **2,3-bisphosphoglycerate (2,3-BPG)** is a metabolic intermediate produced specifically in red blood cells that serves as the primary physiological regulator of hemoglobin's oxygen affinity. - It binds to the central cavity of deoxygenated hemoglobin, stabilizing the tense (T) state and significantly decreasing oxygen affinity, shifting the curve to the right. - Its concentration increases in chronic hypoxic conditions (high altitude, anemia, chronic lung disease), providing sustained adaptation for oxygen delivery to tissues. - **2,3-BPG levels can increase by 50% or more** during chronic hypoxia, representing the most significant **long-term physiological mechanism** for modulating the oxygen dissociation curve. *pH* - A decrease in **pH** (Bohr effect) shifts the oxygen dissociation curve to the right by stabilizing the T state of hemoglobin. - This is primarily an **acute response** to metabolic conditions rather than a sustained regulatory mechanism. - While clinically important, pH changes are typically secondary to metabolic states rather than a primary regulatory mechanism. *Temperature* - An increase in **temperature** causes a rightward shift of the oxygen dissociation curve, promoting oxygen release from hemoglobin. - Temperature effects are generally **passive responses** to environmental or metabolic conditions rather than active regulatory mechanisms. - The magnitude of temperature-induced shifts is typically smaller than those produced by 2,3-BPG in physiological conditions. *All of these* - While pH, temperature, and 2,3-BPG all influence the oxygen dissociation curve, the question asks for the factor with the **most significant influence**. - **2,3-BPG** is unique as the only factor that represents an **active, sustained, physiological regulatory mechanism** specifically evolved for oxygen delivery modulation. - pH and temperature effects are important but represent **passive responses** to metabolic conditions rather than primary regulatory control mechanisms.
Question 10: Which factor predominantly influences the rightward shift of the oxygen dissociation curve?
- A. pH (Bohr effect)
- B. 2,3-Bisphosphoglycerate (2,3-BPG) (Correct Answer)
- C. Temperature increase
- D. Carbon monoxide levels
Explanation: ***2,3-Bisphosphoglycerate (2,3-BPG)*** - **2,3-BPG** is an organic phosphate found in **red blood cells** that serves as the **predominant regulator** of oxygen-hemoglobin affinity under physiological conditions. - An increase in **2,3-BPG** levels binds to the **beta chains of deoxyhemoglobin**, stabilizing the T (tense) state and reducing hemoglobin's affinity for oxygen, thereby shifting the curve to the right and facilitating **oxygen release** to tissues. - **2,3-BPG** is especially important in **chronic adaptations** to hypoxia (high altitude, chronic lung disease, anemia) and is the **primary mechanism** for sustained alterations in oxygen delivery. - Normal RBC 2,3-BPG concentration is approximately equal to hemoglobin concentration, making it a **quantitatively significant** regulatory factor. *pH (Bohr effect)* - A decrease in blood **pH** (increased acidity) due to higher **CO2** and **H+** concentrations also shifts the oxygen dissociation curve to the right via the **Bohr effect**. - While physiologically important for **acute regulation** in metabolically active tissues, the Bohr effect operates in conjunction with other factors rather than as the predominant standalone regulator. - The effect is mediated by **protonation of histidine residues** on hemoglobin, causing conformational changes that reduce oxygen affinity. *Temperature increase* - An increase in **temperature** reduces hemoglobin's affinity for oxygen, shifting the oxygen dissociation curve to the right. - This effect is vital for **oxygen delivery** to actively metabolizing tissues (which generate heat), but is generally a **secondary factor** compared to 2,3-BPG in terms of overall regulation. - The temperature effect is more situational, occurring primarily in tissues with elevated metabolic activity. *Carbon monoxide levels* - **Carbon monoxide (CO)** causes a **leftward shift** of the oxygen dissociation curve, not a rightward shift. - CO binds to hemoglobin with 200-250 times greater affinity than oxygen, forming **carboxyhemoglobin** (COHb). - This not only reduces oxygen-carrying capacity but also **increases hemoglobin's affinity** for the remaining oxygen, making it harder to release oxygen to tissues. - CO poisoning is therefore dangerous both because it displaces oxygen and because it impairs oxygen delivery through leftward shift.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free